Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 8.66B | 9.08B | 9.40B | 9.64B | 10.15B | 10.65B |
Gross Profit | 3.08B | 3.26B | 3.06B | 3.21B | 3.63B | 3.47B |
EBITDA | 686.66M | 1.01B | 703.00M | 1.02B | 1.41B | 994.66M |
Net Income | 433.67M | 450.65M | 323.84M | 457.08M | 615.47M | 444.21M |
Balance Sheet | ||||||
Total Assets | 17.76B | 17.32B | 18.63B | 18.83B | 18.64B | 18.83B |
Cash, Cash Equivalents and Short-Term Investments | 5.64B | 5.45B | 5.34B | 5.53B | 6.11B | 7.48B |
Total Debt | 1.61B | 1.42B | 1.92B | 2.03B | 2.25B | 2.58B |
Total Liabilities | 4.09B | 3.65B | 4.69B | 5.11B | 5.22B | 6.02B |
Stockholders Equity | 12.54B | 12.56B | 12.64B | 12.40B | 12.04B | 11.54B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 169.94M | 49.76M | -337.95M | -1.02B | -666.10M |
Operating Cash Flow | 0.00 | 340.99M | 530.27M | 279.42M | -594.86M | -411.82M |
Investing Cash Flow | 0.00 | 1.28B | -44.99M | -700.91M | -832.14M | -237.84M |
Financing Cash Flow | 0.00 | -735.83M | -349.43M | -540.72M | -580.87M | 1.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥73.60B | 13.42 | 2.89% | 3.74% | 4.01% | ||
72 Outperform | ¥12.84B | 9.61 | 5.02% | 4.80% | 32.85% | ||
71 Outperform | ¥6.44B | 12.97 | 2.61% | 13.34% | -74.02% | ||
69 Neutral | ¥17.69B | 16.64 | 3.34% | 2.10% | 5.08% | ||
68 Neutral | ¥81.74B | 13.83 | 3.37% | 7.11% | 7.49% | ||
62 Neutral | ¥9.19B | 25.33 | 2.44% | 4.03% | -2.88% | ||
62 Neutral | £500.82M | 27.12 | 0.85% | 2.82% | 3.88% | -21.07% |